EP Patent
EP0646592A1 — Estradiol derivative-alkylating agent conjugate
Assigned to Kureha Corp · Expires 1995-04-05 · 31y expired
What this patent protects
An estradiol derivative-alkylating agent conjugate of formula (I'): wherein each R¹ is independently C₁₋₄ alkoxy; R² is acyl or benzyl; m is an integer of 1 to 3; and n is an integer of 0 to 3.
USPTO Abstract
An estradiol derivative-alkylating agent conjugate of formula (I'): wherein each R¹ is independently C₁₋₄ alkoxy; R² is acyl or benzyl; m is an integer of 1 to 3; and n is an integer of 0 to 3.
Drugs covered by this patent
- Slynd (DROSPIRENONE) · Exeltis Usa Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.